{"entity":{"type":"insider","cik":"0001328034","url":"/insider/0001328034","json_url":"/insider/0001328034.json","name":"CAPEK JOHN M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":98,"n_filings":10,"first":"2012-03-07","last":"2021-12-15","span_basis":"filed_date"},"name_variants":[{"name":"CAPEK JOHN M","source":"filing","n_filings":10,"first_seen":"2012-03-07","last_seen":"2021-12-15"}],"transactions":[{"id":4199079,"accession":"0001415889-21-005966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-005966","line_url":"/filing/0001415889-21-005966#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149600.0,"shares_display":"149,600","price_per_share":135.0515,"price_display":"135.05","price_state":"stated","total_value":20203704.4,"total_display":"20,203,704.40","total_whole":"20,203,704","shares_owned_after":321398.0,"shares_owned_after_display":"321,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":2310816,"accession":"0001179110-20-009446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009446","line_url":"/filing/0001179110-20-009446#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52300.0,"shares_display":"52,300","price_per_share":111.86,"price_display":"111.86","price_state":"stated","total_value":5850278.0,"total_display":"5,850,278.00","total_whole":"5,850,278","shares_owned_after":316800.0,"shares_owned_after_display":"316,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-27","filed_date":"2020-08-31","scope":"insider"},{"id":2150722,"accession":"0001179110-20-005070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-005070","line_url":"/filing/0001179110-20-005070","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50100.0,"shares_display":"50,100","price_per_share":95.87477429141717,"price_display":"95.87","price_state":"stated","total_value":4803326.192,"total_display":"4,803,326.19","total_whole":"4,803,326","shares_owned_after":335501.0,"shares_owned_after_display":"335,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-21","filed_date":"2020-04-23","scope":"insider","n_lines":2},{"id":7954797,"accession":"0001179110-19-008035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-008035","line_url":"/filing/0001179110-19-008035#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46900.0,"shares_display":"46,900","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":3986500.0,"total_display":"3,986,500.00","total_whole":"3,986,500","shares_owned_after":308535.0,"shares_owned_after_display":"308,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-21","scope":"insider"},{"id":6656128,"accession":"0001179110-18-009933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-009933","line_url":"/filing/0001179110-18-009933#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64900.0,"shares_display":"64,900","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":4218500.0,"total_display":"4,218,500.00","total_whole":"4,218,500","shares_owned_after":298300.0,"shares_owned_after_display":"298,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-25","filed_date":"2018-07-26","scope":"insider"},{"id":4287904,"accession":"0001179110-17-002952","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-17-002952","line_url":"/filing/0001179110-17-002952#line-3","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93400.0,"shares_display":"93,400","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":4203000.0,"total_display":"4,203,000.00","total_whole":"4,203,000","shares_owned_after":288797.0,"shares_owned_after_display":"288,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-22","scope":"insider"},{"id":8800911,"accession":"0001179110-15-002009","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-15-002009","line_url":"/filing/0001179110-15-002009","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9935.0,"shares_display":"9,935","price_per_share":45.8319124308002,"price_display":"45.83","price_state":"stated","total_value":455340.05,"total_display":"455,340.05","total_whole":"455,340","shares_owned_after":232980.0,"shares_owned_after_display":"232,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider","n_lines":9},{"id":8738722,"accession":"0001179110-15-002008","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001179110-15-002008","line_url":"/filing/0001179110-15-002008","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38773.0,"shares_display":"38,773","price_per_share":45.76457792793955,"price_display":"45.76","price_state":"stated","total_value":1774429.98,"total_display":"1,774,429.98","total_whole":"1,774,430","shares_owned_after":266053.0,"shares_owned_after_display":"266,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider","n_lines":30},{"id":8404073,"accession":"0001179110-15-002007","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001179110-15-002007","line_url":"/filing/0001179110-15-002007#line-30","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3987.0,"shares_display":"3,987","price_per_share":45.66,"price_display":"45.66","price_state":"stated","total_value":182046.42,"total_display":"182,046.42","total_whole":"182,046","shares_owned_after":291553.0,"shares_owned_after_display":"291,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8404070,"accession":"0001179110-15-002007","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001179110-15-002007","line_url":"/filing/0001179110-15-002007#line-29","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":45.68,"price_display":"45.68","price_state":"stated","total_value":123336.0,"total_display":"123,336.00","total_whole":"123,336","shares_owned_after":284653.0,"shares_owned_after_display":"284,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8404066,"accession":"0001179110-15-002007","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001179110-15-002007","line_url":"/filing/0001179110-15-002007#line-28","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":45.65,"price_display":"45.65","price_state":"stated","total_value":123255.0,"total_display":"123,255.00","total_whole":"123,255","shares_owned_after":296140.0,"shares_owned_after_display":"296,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8404064,"accession":"0001179110-15-002007","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001179110-15-002007","line_url":"/filing/0001179110-15-002007#line-27","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001328034","owner_name":"CAPEK JOHN M","owner_display_name":"CAPEK JOHN M","owner_url":"/insider/0001328034","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":45.69,"price_display":"45.69","price_state":"stated","total_value":118794.0,"total_display":"118,794.00","total_whole":"118,794","shares_owned_after":281353.0,"shares_owned_after_display":"281,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"}],"collapsed":true,"next_cursor":"2015-02-04|8404064","ledger_fault":false,"count":{"value":98,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":98,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":98},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (EXECUTIVE VICE PRESIDENT)","n_filings":10,"first_seen":"2012-03-07","last_seen":"2021-12-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001328034","retrieved_at":"2026-08-26T02:40:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}